IP Library Patent Application 19412163
Patent Application
App. No. 19/412,163

SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/412,163
Abstract

Disclosed are compounds of formulae I and II, and pharmaceutically acceptable salts and prodrugs thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant complement system activity.

Claims (16)

1 . A compound, or a pharmaceutically acceptable salt thereof, selected from the group consisting of:

2 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

3 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

4 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

5 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

6 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

7 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

8 . The compound of claim 1 , or a pharmaceutically acceptable salt thereof, having the following structure:

9 . The compound of claim 1 , wherein the compound is in the form of a hydrochloride salt.

10 . The compound of claim 2 , wherein the compound is in the form of a hydrochloride salt.

11 . The compound of claim 3 , wherein the compound is in the form of a hydrochloride salt.

12 . The compound of claim 4 , wherein the compound is in the form of a hydrochloride salt.

13 . The compound of claim 5 , wherein the compound is in the form of a hydrochloride salt.

14 . The compound of claim 6 , wherein the compound is in the form of a hydrochloride salt.

15 . The compound of claim 7 , wherein the compound is in the form of a hydrochloride salt.

16 . The compound of claim 8 , wherein the compound is in the form of a hydrochloride salt.

Assignments (1)
SECURITY INTEREST Recorded Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →